A recent study on astrocytes differentiated from induced pluripotent stem cells (iPSCs) derived from AD patients with PSEN1 mutations demonstrated high OCR and ROS levels in these cells, which could be rescued by CRISPR/Cas9 correction of the mutation (Oksanen et al., 2017). This evidence concerns the gene PSEN1 and Alzheimer disease.